Financials Medicale Corp.

Equities

MCLE

US58464K1025

Pharmaceuticals

Market Closed - OTC Markets 03:55:46 2024-07-16 pm EDT 5-day change 1st Jan Change
0.33 USD -2.94% Intraday chart for Medicale Corp. +131.25% +120.00%

Valuation

Fiscal Period: September 2022 2023
Capitalization 1 11.84 2.605
Enterprise Value (EV) 1 11.86 2.625
P/E ratio -255 x -70.1 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -
FCF Yield - -
Price to Book -216 x -64 x
Nbr of stocks (in thousands) 5,920 5,920
Reference price 2 2.000 0.4400
Announcement Date 12/2/22 1/2/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2020 2021 2022 2023
Net sales - - - -
EBITDA - - - -
EBIT 1 -0.0231 -0.0322 -0.0464 -0.0376
Operating Margin - - - -
Earnings before Tax (EBT) 1 -0.0231 -0.0322 -0.0464 -0.0376
Net income 1 -0.0231 -0.0322 -0.0464 -0.0371
Net margin - - - -
EPS - -0.008892 -0.007841 -0.006273
Free Cash Flow - -0.005695 - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 11/12/20 12/15/21 12/2/22 1/2/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2020 2021 2022 2023
Net Debt 1 0 - 0.02 0.02
Net Cash position 1 - 0.01 - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - -0.01 - -
ROE (net income / shareholders' equity) - 659% 147% 78.7%
ROA (Net income/ Total Assets) - -99.3% -205% -
Assets 1 - 0.0324 0.0226 -
Book Value Per Share 2 -0 -0 -0.0100 -0.0100
Cash Flow per Share - 0 - 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 11/12/20 12/15/21 12/2/22 1/2/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. MCLE Stock
  4. Financials Medicale Corp.